Pasithea Therapeutics Ownership | Who Owns Pasithea Therapeutics?

Pasithea Therapeutics Ownership Summary

Pasithea Therapeutics is owned by 0.99% institutional investors, and 99.01% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.29% of its assets in Pasithea Therapeutics shares.

KTTA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Pasithea Therapeutics	0.99%	-	99.01%
Sector	Healthcare Stocks	46.98%	7.90%	45.12%
Industry	Biotech Stocks	44.85%	7.67%	47.48%

Institutional Shareholders

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2023	8	-33.33%	248,808	-2.59%	-	103.48%	3	-57.14%	2	-33.33%
Sep 30, 2023	12	-	255,417	-32.44%	-	46.49%	7	40.00%	3	-
Jun 30, 2023	12	-	378,085	-1.83%	1	66.46%	5	25.00%	3	-
Mar 31, 2023	12	9.09%	385,124	-39.00%	1	23.62%	4	-50.00%	3	50.00%
Dec 31, 2022	11	37.50%	631,393	-22.91%	2	26.27%	8	100.00%	2	100.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Extended Market Index	3.02K	0.29%	-1.39K
NT Ext Equity Mkt Idx Fd - L	1.67K	0.16%	-
Northern Trust Extended Eq Market Idx	1.67K	0.16%	-
Fidelity Series Total Market Index	960.00	0.09%	-
NT Ext Eq Mkt Indx Fd DC Lending Tier 5	258.00	0.02%	-
Spartan Total Market Index Pool E	229.00	0.02%	-
Fidelity U.S. Equity Index Ins Trust	10.00	0.00%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 02, 2023	STEINMAN LAWRENCE	-	Buy	$12.93K
Oct 17, 2022	Delaney David	-	Buy	$1.11K
Sep 29, 2022	Shahinian Eric	Member of 10% owner group	Buy	$7.76K
Sep 28, 2022	Shahinian Eric	Member of 10% owner group	Buy	$68.54K
Sep 28, 2022	Camac Partners, LLC		Buy	$7.76K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	-	-
2024 Q1	-	-
2023 Q2	1	-
2022 Q4	1	-
2022 Q3	13	-

KTTA Ownership FAQ

Who Owns Pasithea Therapeutics?

Pasithea Therapeutics shareholders are primarily institutional investors at 0.99%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Pasithea Therapeutics's industry, Biotech Stocks , is 44.85%, which Pasithea Therapeutics falls below.

Does Blackrock own Pasithea Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Pasithea Therapeutics.

Who is the top mutual fund holder of Pasithea Therapeutics shares?

Fidelity Extended Market Index is the top mutual fund holder of Pasithea Therapeutics shares, with 0.29% of its total shares outstanding invested in 3.02K Pasithea Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools